Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach.
Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G, Sorrentino F, D'Ascola DG, Spasiano A, Filosa A, Cuccia L, Dello Iacono N, Forni G, Caruso V, Maggio A, Pitrolo L, Peluso A, De Marchi D, Positano V, Wood JC. Pepe A, et al. Among authors: peluso a. Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):299-309. doi: 10.1093/ehjci/jex012. Eur Heart J Cardiovasc Imaging. 2018. PMID: 28200076
The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Peluso A, Messina G, Spasiano A, Allò M, Bisconte MG, Putti MC, Casini T, Dello Iacono N, Celli M, Vitucci A, Giuliano P, Peritore G, Renne S, Righi R, Positano V, De Sanctis V, Meloni A. Pepe A, et al. Among authors: peluso a. Diabetes Care. 2020 Nov;43(11):2830-2839. doi: 10.2337/dc20-0908. Epub 2020 Sep 4. Diabetes Care. 2020. PMID: 32887708
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.
Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P. Pepe A, et al. Among authors: peluso a. J Cardiovasc Magn Reson. 2013 Jan 16;15(1):1. doi: 10.1186/1532-429X-15-1. J Cardiovasc Magn Reson. 2013. PMID: 23324167 Free PMC article.
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients.
Pepe A, Meloni A, Borsellino Z, Cuccia L, Borgna-Pignatti C, Maggio A, Restaino G, Gagliardotto F, Caruso V, Spasiano A, Filosa A, Centra M, D'Ascola D, Quarta A, Peluso A, Midiri M, Rossi G, Positano V, Capra M. Pepe A, et al. Among authors: peluso a. J Cardiovasc Med (Hagerstown). 2015 Oct;16(10):689-95. doi: 10.2459/JCM.0000000000000278. J Cardiovasc Med (Hagerstown). 2015. PMID: 26090920
The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
Ricchi P, Meloni A, Pistoia L, Spasiano A, Spiga A, Allò M, Gamberini MR, Lisi R, Campisi S, Peluso A, Missere M, Renne S, Mangione M, Positano V, Pepe A. Ricchi P, et al. Among authors: peluso a. Ann Hematol. 2018 Oct;97(10):1925-1932. doi: 10.1007/s00277-018-3397-3. Epub 2018 Jun 21. Ann Hematol. 2018. PMID: 29926157
Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
Meloni A, Restaino G, Missere M, De Marchi D, Positano V, Valeri G, Giuseppe D'Ascola D, Peluso A, Caterina Putti M, Lendini M, Giovanna Neri M, Midiri M, Sallustio G, Pepe A. Meloni A, et al. Among authors: peluso a. Am J Hematol. 2015 Sep;90(9):E189-90. doi: 10.1002/ajh.24081. Am J Hematol. 2015. PMID: 26044155 Free article. No abstract available.
Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
Fragasso A, Ciancio A, Mannarella C, Gaudiano C, Scarciolla O, Ottonello C, Francone M, Nardella M, Peluso A, Melpignano A, Veglio MR, Quarta G, Turchetti C. Fragasso A, et al. Among authors: peluso a. Eur J Intern Med. 2011 Feb;22(1):62-5. doi: 10.1016/j.ejim.2010.10.005. Epub 2010 Nov 24. Eur J Intern Med. 2011. PMID: 21238896
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
Casale M, Forni GL, Cassinerio E, Pasquali D, Origa R, Serra M, Campisi S, Peluso A, Renni R, Cattoni A, De Michele E, Allò M, Poggi M, Ferrara F, Di Concilio R, Sportelli F, Quarta A, Putti MC, Notarangelo LD, Sau A, Ladogana S, Tartaglione I, Picariello S, Marcon A, Sturiale P, Roberti D, Lazzarino AI, Perrotta S. Casale M, et al. Among authors: peluso a. Haematologica. 2022 Feb 1;107(2):467-477. doi: 10.3324/haematol.2020.272419. Haematologica. 2022. PMID: 33406815 Free PMC article.
213 results